Skip to content
Biodatica
Start free

EVIVE Biotechnology

Shanghai, Shanghai Municipality

OncologyPhase III
Compare Sign in to watch

What changed

Study registered, no phase assigned: Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

1w agoTrial registeredJul 8, 2026Source filing (opens the source filing in a new tab)

Momentum

80no change

Momentum 80 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase III

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

277 pre-ticker oncology companies at Phase III

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Dec 23, 2024

    Breast Cancer Female, HER2-negative Breast Cancer · COMPLETED · sponsor: Fudan University · Pilot Study of Neoadjuvant Chemotherapy Combined With Immunotherapy and Multimodal Thermal Therapy for HER2-negative Breast Cancer

    ClinicalTrials.gov · NCT06636591 (opens the source filing in a new tab)

  2. Trial

    Study registered

    Dec 5, 2024

    Breast Cancer, Age · RECRUITING · sponsor: Fudan University · The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer

    ClinicalTrials.gov · NCT06718010 (opens the source filing in a new tab)

  3. Trial

    PHASE3 registered

    Apr 12, 2018

    Breast Cancer, Neutropenia · COMPLETED · sponsor: EVIVE Biotechnology · Study to Compare the Efficacy and Safety of F-627 and GRAN®

    ClinicalTrials.gov · NCT04174599 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources